Tag: autoimmune disease

Clinical Trials, Research and Development

The future of AI drug discovery & development in immunology and GPCR research

September 16, 2022

Via: Pharmaphorum

A mere six months ago Verily launched the study with Sosei Heptares – a global leader in GPCR structure-based drug design – with an aim to “prioritise protein targets for therapeutic targeting in immune-mediated disease”. Now, Verily has announced that […]

Mergers and Acquisitions

J&J to Acquire Momenta Pharmaceuticals for $6.5B

August 19, 2020

Via: Contract Pharma

Johnson & Johnson has entered into a definitive agreement to acquire Momenta Pharmaceuticals, Inc. for approximately $6.5 billion in cash. This acquisition expands Janssen Pharmaceutical’s portfolio in immune-mediated diseases into autoantibody-driven disease. J&J gains global rights to nipocalimab (M281), a […]